1. Home
  2. CBL vs VIR Comparison

CBL vs VIR Comparison

Compare CBL & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • VIR
  • Stock Information
  • Founded
  • CBL 1978
  • VIR 2016
  • Country
  • CBL United States
  • VIR United States
  • Employees
  • CBL N/A
  • VIR N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBL Real Estate
  • VIR Health Care
  • Exchange
  • CBL Nasdaq
  • VIR Nasdaq
  • Market Cap
  • CBL 771.2M
  • VIR 844.9M
  • IPO Year
  • CBL 1993
  • VIR 2019
  • Fundamental
  • Price
  • CBL $25.51
  • VIR $5.23
  • Analyst Decision
  • CBL
  • VIR Strong Buy
  • Analyst Count
  • CBL 0
  • VIR 7
  • Target Price
  • CBL N/A
  • VIR $32.86
  • AVG Volume (30 Days)
  • CBL 140.5K
  • VIR 1.4M
  • Earning Date
  • CBL 08-08-2025
  • VIR 07-31-2025
  • Dividend Yield
  • CBL 10.98%
  • VIR N/A
  • EPS Growth
  • CBL 2069.88
  • VIR N/A
  • EPS
  • CBL 2.16
  • VIR N/A
  • Revenue
  • CBL $528,212,000.00
  • VIR $20,861,000.00
  • Revenue This Year
  • CBL N/A
  • VIR N/A
  • Revenue Next Year
  • CBL N/A
  • VIR N/A
  • P/E Ratio
  • CBL $11.79
  • VIR N/A
  • Revenue Growth
  • CBL 0.03
  • VIR N/A
  • 52 Week Low
  • CBL $21.10
  • VIR $4.32
  • 52 Week High
  • CBL $33.54
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • CBL 54.33
  • VIR 50.23
  • Support Level
  • CBL $24.33
  • VIR $5.02
  • Resistance Level
  • CBL $26.27
  • VIR $5.34
  • Average True Range (ATR)
  • CBL 0.52
  • VIR 0.25
  • MACD
  • CBL 0.02
  • VIR 0.03
  • Stochastic Oscillator
  • CBL 60.67
  • VIR 47.53

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: